BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7858884)

  • 1. Location of the sulphonylurea receptor at the cytoplasmic face of the beta-cell membrane.
    Schwanstecher M; Schwanstecher C; Dickel C; Chudziak F; Moshiri A; Panten U
    Br J Pharmacol; 1994 Nov; 113(3):903-11. PubMed ID: 7858884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation of KATP channel and sulphonylurea receptor in the rat clonal insulin-secreting cell line, CRI-D11.
    Khan RN; Hales CN; Ozanne SE; Adogu AA; Ashford ML
    Proc Biol Sci; 1993 Sep; 253(1338):225-31. PubMed ID: 7694299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of N-benzoyl-D-phenylalanine and related compounds with the sulphonylurea receptor of beta-cells.
    Schwanstecher C; Meyer M; Schwanstecher M; Panten U
    Br J Pharmacol; 1998 Mar; 123(6):1023-30. PubMed ID: 9559882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of trypsin on ATP-sensitive potassium channel properties and sulfonylurea receptors in the CRI-G1 insulin-secreting cell line.
    Lee K; Ozanne SE; Rowe IC; Hales CN; Ashford ML
    Mol Pharmacol; 1994 Jul; 46(1):176-85. PubMed ID: 8058051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets.
    Panten U; Burgfeld J; Goerke F; Rennicke M; Schwanstecher M; Wallasch A; Zünkler BJ; Lenzen S
    Biochem Pharmacol; 1989 Apr; 38(8):1217-29. PubMed ID: 2650685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mg(2+)-dependent inhibition of KATP by sulphonylureas in CRI-G1 insulin-secreting cells.
    Lee K; Ozanne SE; Hales CN; Ashford ML
    Br J Pharmacol; 1994 Feb; 111(2):632-40. PubMed ID: 8004407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural requirements of sulphonylureas and analogues for interaction with sulphonylurea receptor subtypes.
    Meyer M; Chudziak F; Schwanstecher C; Schwanstecher M; Panten U
    Br J Pharmacol; 1999 Sep; 128(1):27-34. PubMed ID: 10498831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular localization and molecular heterogeneity of the sulphonylurea receptor in insulin-secreting cells.
    Ozanne SE; Guest PC; Hutton JC; Hales CN
    Diabetologia; 1995 Mar; 38(3):277-82. PubMed ID: 7758873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sulphonylureas and diazoxide on insulin secretion and nucleotide-sensitive channels in an insulin-secreting cell line.
    Sturgess NC; Kozlowski RZ; Carrington CA; Hales CN; Ashford ML
    Br J Pharmacol; 1988 Sep; 95(1):83-94. PubMed ID: 3146398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic exposure to tolbutamide and glibenclamide impairs insulin secretion but not transcription of K(ATP) channel components.
    Ball AJ; McCluskey JT; Flatt PR; McClenaghan NH
    Pharmacol Res; 2004 Jul; 50(1):41-6. PubMed ID: 15082027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of MgATP on pinacidil-induced displacement of glibenclamide from the sulphonylurea receptor in a pancreatic beta-cell line and rat cerebral cortex.
    Schwanstecher M; Brandt C; Behrends S; Schaupp U; Panten U
    Br J Pharmacol; 1992 Jun; 106(2):295-301. PubMed ID: 1393263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible involvement of protein phosphorylation in the regulation of the sulphonylurea receptor of a pancreatic beta-cell line, HIT T15.
    Niki I; Ashcroft SJ
    Biochim Biophys Acta; 1991 Dec; 1133(1):95-101. PubMed ID: 1836360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of tolbutamide and cytosolic nucleotides in controlling the ATP-sensitive K+ channel in mouse beta-cells.
    Schwanstecher C; Dickel C; Panten U
    Br J Pharmacol; 1994 Jan; 111(1):302-10. PubMed ID: 8012711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promiscuous coupling between the sulphonylurea receptor and inwardly rectifying potassium channels.
    Ammälä C; Moorhouse A; Gribble F; Ashfield R; Proks P; Smith PA; Sakura H; Coles B; Ashcroft SJ; Ashcroft FM
    Nature; 1996 Feb; 379(6565):545-8. PubMed ID: 8596634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic inhibition impairs ATP-sensitive K+ channel block by sulfonylurea in pancreatic beta-cells.
    Mukai E; Ishida H; Kato S; Tsuura Y; Fujimoto S; Ishida-Takahashi A; Horie M; Tsuda K; Seino Y
    Am J Physiol; 1998 Jan; 274(1):E38-44. PubMed ID: 9458745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor.
    Tucker SJ; Gribble FM; Zhao C; Trapp S; Ashcroft FM
    Nature; 1997 May; 387(6629):179-83. PubMed ID: 9144288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulphonylurea receptor 2B and Kir6.1 form a sulphonylurea-sensitive but ATP-insensitive K+ channel.
    Yamada M; Isomoto S; Matsumoto S; Kondo C; Shindo T; Horio Y; Kurachi Y
    J Physiol; 1997 Mar; 499 ( Pt 3)(Pt 3):715-20. PubMed ID: 9130167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the solubilized glibenclamide receptor in a hamster pancreatic beta-cell line, HIT T15.
    Niki I; Welsh M; Berggren PO; Hubbard P; Ashcroft SJ
    Biochem J; 1991 Aug; 277 ( Pt 3)(Pt 3):619-24. PubMed ID: 1908219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Block of pancreatic ATP-sensitive K+ channels and insulinotrophic action by the antiarrhythmic agent, cibenzoline.
    Ishida-Takahashi A; Horie M; Tsuura Y; Ishida H; Ai T; Sasayama S
    Br J Pharmacol; 1996 Apr; 117(8):1749-55. PubMed ID: 8732286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The beta-cell glibenclamide receptor is an ADP-binding protein.
    Niki I; Nicks JL; Ashcroft SJ
    Biochem J; 1990 Jun; 268(3):713-8. PubMed ID: 2114099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.